Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2016

Aug 5, 2016

30597_dirs_2016-08-05_85a63bfc-b6ca-4a6c-90a2-f5740475755f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2016-08-03

Reporting Person: Zanotti Katherine S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-08-03 Common Stock P 3380 $17.9329 Acquired 105927 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.93 to $17.94, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.